Nissin Medical Industries Co. Ltd., commonly referred to as Nissin, is a prominent player in the medical equipment industry, headquartered in Japan. Established in 1950, the company has made significant strides in the development and manufacturing of high-quality medical devices, particularly in the field of wheelchairs and mobility aids. With a strong operational presence across Asia and beyond, Nissin is renowned for its innovative approach to enhancing patient mobility and comfort. Their core products, including advanced wheelchairs and rehabilitation equipment, are distinguished by their ergonomic design and cutting-edge technology. Nissin's commitment to quality and user-centric solutions has solidified its market position, making it a trusted name among healthcare professionals and patients alike. The company continues to set benchmarks in the industry, reflecting its dedication to improving the lives of individuals with mobility challenges.
How does Nissin Medical Industries Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Motor Vehicle Retail Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Nissin Medical Industries Co. Ltd's score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
As of 2019, Nissin Medical Industries Co. Ltd reported total carbon emissions of approximately 32,000,000 kg CO2e, comprising 16,252,000 kg CO2e from Scope 1, 14,403,000 kg CO2e from Scope 2, and 2,961,000 kg CO2e from Scope 3 emissions. Over the years, the company has shown fluctuations in its emissions, with Scope 1 emissions peaking at about 16,590,000 kg CO2e in 2018 and Scope 2 emissions reaching a high of approximately 14,403,000 kg CO2e in 2019. Despite these figures, Nissin Medical Industries has not publicly disclosed specific reduction targets or initiatives aimed at decreasing its carbon footprint. The absence of documented climate pledges or science-based targets suggests that while the company is aware of its emissions, it may not yet have formalised a comprehensive strategy for significant reductions. Overall, Nissin Medical Industries operates within a context where many companies are increasingly committing to ambitious climate goals, highlighting the importance of establishing clear reduction pathways to align with global climate objectives.
Access structured emissions data, company-specific emission factors, and source documents
2015 | 2016 | 2017 | 2018 | 2019 | |
---|---|---|---|---|---|
Scope 1 | 15,988,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 12,207,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | 2,939,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nissin Medical Industries Co. Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.